The aim of this paper is to decompose cross-national differences in self-reported general health into parts explained by differences in "true" health, measured by diagnosed conditions and measurements, and parts explained by cross-cultural differences in response styles. The data used were drawn from the Survey of Health, Ageing and Retirement in Europe 2004 (SHARE), using information from 22,000 ...
The pharmaceutical industry employs around 106 000 people and produces a good 9 billion euros or 2.5% of value added in the manufacturing sector in Germany. But it contributes a bigger part to value added and employment in the economy as a whole than these figures show. Its particular role results from the fact that almost its entire output (96%) goes direct to end user (final demand), while demand ...
This paper discusses the role of private health insurance (PHI) in developing countries. Three major findings emerge from a comprehensive and systematic review of the performance of PHI in five regions of the developing world. First, PHI involving pre-payment and risk sharing currently only plays a marginal role in the developing world. Second, in many countries the importance of PHI to finance health ...
Background: In the next few decades the population in all EU-countries will age rapidly. This could have a major impact on the health care sector. This study analyses the effect of population ageing on utilisation in two key sectors of the health care system, namely hospital care and long-term care in Germany, up to 2020 with an outlook to 2050. Methods: Two population scenarios, one with constant, ...
Previous cross-sectional and intervention studies have suggested that pet owners may enjoy better physical and mental health than non-owners. This paper presents longitudinal evidence from a major national representative longitudinal survey: the German Socio-Economic Panel (SOEP). Because the data are longitudinal, it is possible to assess the impact on health outcomes (measured by number of doctor ...
Some people believe that the impact of population ageing on future health care ex-penditures will be quite moderate due to the high costs of dying. If not age per se but proximity to death determines the bulk of expenditures, a shift in the mortality risk to higher ages will not affect lifetime health care expenditures as death occurs only once in every life. We attempt to take this effect into account ...
